CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (37,268,007)	$ (22,751,389)
Adjustment to reconcile to net loss to net cash used in operating activities:
Depreciation expense	170,337	30,652
Right-of-use asset amortization	414,444	75,922
Intangible asset amortization	22,737
Stock based compensation expense	3,016,283	1,170,040
Net amortization of premium on marketable securities	47,979	8,548
(Increase) decrease in:
Accounts receivable	175,860	28,735
Prepaid expenses and other current assets	166,413	(3,122,547)
Other assets	(356,117)
Increase (decrease) in:
Accounts payable	944,040	314,616
Accrued expenses	385,536	2,689,860
Lease liability	(116,718)	(56,329)
Other liabilities	44,562
Net cash used in operating activities	(32,352,651)	(21,611,892)
Cash flows from investing activities:
Purchases of property and equipment	(673,181)	(47,734)
Purchases of marketable securities	(37,726,144)	(52,760,299)
Maturities of marketable securities	72,078,000
Net cash provided by (used in) investing activities	33,678,675	(52,808,033)
Cash flows from financing activities:
Proceeds from exercise of stock options	258,281	346,915
Proceeds from initial public offering of common stock, net of commissions and underwriting		120,318,750
Payment of initial public offering costs		(2,124,317)
Payment of offering costs	(54,600)
Proceeds from exercise of warrants		927,125
Net cash provided by financing activities	203,681	144,257,324
Net increase in cash and cash equivalents	1,529,705	69,837,399
Cash and cash equivalents at beginning of period	74,888,145	37,090,151
Cash and cash equivalents at end of period	76,417,850	106,927,550
Supplemental disclosures of noncash information:
Conversion of convertible Series A and B preferred stock into common stock		82,892,701
Reduction of right of use asset and lease liability in connection with lease modification	396,901
Deferred offering costs included in accounts payable and accrued expenses	$ 224,448
Series B Preferred Stock
Cash flows from financing activities:
Proceeds from the issuance of Series B preferred stock, net of issuance costs		$ 24,788,851